Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Retinal Diseases

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Retinal Diseases in 2 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Retinal Diseases: Diseases involving the RETINA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hurst, J1
Mueller-Buehl, AM1
Hofmann, L1
Kuehn, S1
Herms, F1
Schnichels, S1
Joachim, SC1
Sennlaub, F1
Courtois, Y1
Goureau, O1

Other Studies

2 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Retinal Diseases

ArticleYear
iNOS-inhibitor driven neuroprotection in a porcine retina organ culture model.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:7

    Topics: Amacrine Cells; Amidines; Animals; Apoptosis; Benzylamines; Cell Hypoxia; Disease Models, Animal; Hu

2020
Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, May-15, Volume: 22, Issue:10

    Topics: Aging; Amidines; Animals; Animals, Newborn; Apoptosis; Benzylamines; Cell Count; Crosses, Genetic; D

2002